Interaction of digoxin with hydralazine and prazosin
Halawa, B.; Mazurek, W.
Polski Tygodnik Lekarski 41(48): 1521-1523
1986
ISSN/ISBN: 0032-3756 PMID: 3588366 Document Number: 276782
Document emailed within 1 workday
Related Documents
Laslett, L.J.; DeMaria, A.N.; Amsterdam, E.A.; Mason, D.T. 1978: Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy Archives of Internal Medicine 138(5): 819-820Luca, C.; Graziani, G.; Griffini, P. 1981: Antihypertensive activity of minoxidil, hydralazine, prazosin, phentolamine and clonidine in spontaneously hypertensive rats. Comparison with therapeutic dosages Bollettino Chimico Farmaceutico 120(6): 343-350
Shepherd, A.M.; Ludden, T.M.; Haegele, K.D.; Talseth, T.; McNay, J.L. 1979: Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans Research Communications in Chemical Pathology and Pharmacology 26(1): 129-144
Grissette, D.E.; Stewart, S.E.; Coker, S.T.; Davidson, P.P.; Williams, B.B. 1980: Biologic interaction of gamma radiation with phenylbutazone, phenytoin, or hydralazine Research Communications in Chemical Pathology and Pharmacology 29(3): 589-597
Bolt, G.R.; Saxena, P.R. 1984: Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits Journal of Pharmacology and Experimental Therapeutics 230(1): 205-213
Talseth, T.; Haegele, K.D.; McNay, J.L.; Skrdlant, H.B.; Clementi, W.A.; Shepherd, A.M. 1979: Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazone Journal of Pharmacology and Experimental Therapeutics 211(3): 509-513
Mazurek, W.; Haczyński, J. 1993: Interaction of captopril and digoxin Polski Tygodnik Lekarski 48(50-52): 834-835
Halawa, B.; Mazurek, W. 1980: Interaction between digoxin and quinidine Polski Tygodnik Lekarski 35(51): 1993-1995
Ravikumar, A.; Augustine, J.; Kurup, P.A. 2001: Studies on digoxin--14C-acetate incorporation in to digoxin and degenerative changes in the brain in rats administered digoxin Indian Journal of Experimental Biology 39(6): 537-541
Koren, G. 1983: Digoxin-verapamil interaction--is it mutual? Circulation 67(3): 707
Mayer, O.; Cepelák, V.; Suchová, H. 1984: Antihypertensive effectiveness of a domestically manufactured preparation of prazosin (Prazosin VUFB) Vnitrni Lekarstvi 30(9): 884-892
Hartmann, M.; Huber, R.; Bliesath, H.; Steinijans, V.W.; Koch, H.J.; Wurst, W.; Kunz, K. 1996: Lack of interaction between pantoprazole and digoxin at therapeutic doses in man International Journal of Clinical Pharmacology and Therapeutics 34(1 Suppl): S67-S71
Kokwaro, G.O. 1995: Pharmacokinetic basis of nifedipine-digoxin interaction: a commentary East African Medical Journal 72(10): 684-687
Horowitz, J.D.; Barry, W.H.; Smith, T.W. 1982: Lack of interaction between digoxin and quinidine in cultured heart cells Journal of Pharmacology and Experimental Therapeutics 220(3): 488-493
Ellingsen, O.; Kjekshus, J. 1984: Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 104(9): 657-660
Koren, G.; Soldin, S.; MacLeod, S.M. 1983: Interaction of digoxin with verapamil, indomethacin, and other coadministered drugs: a comparative study in rat tissue Progress in Clinical and Biological Research 135: 417-420
Cabane, J.; Penin, I.; Bouslama, K.; Benchouieb, A.; Giral, P.; Picard, O.; Wattiaux, M.J.; Cheymol, G.; Souvignet, G.; Imbert, J.C. 1991: Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of interaction with the pharmacokinetics of digoxin Therapie 46(3): 235-240
Ware, J.A.; Young, J.B.; Luchi, R.J.; Smith, T.W.; Haber, E.; Butler, V.P. 1983: Treatment of severe digoxin toxicity with digoxin-specific antibodies: a case report Texas Medicine 79(1): 57-59
Nyberg, L.; Andersson, K.E.; Fagerström, P.O. 1977: Bioavailability of digoxin from tablets. IV. Urinary excretion of digoxin during multiple dose treatment Acta Pharmaceutica Suecica 14(2): 119-136
McCarthy, R.C. 1985: Minimizing the effect of digoxin-like immunoreactive substances in immunoassays for digoxin in neonatal serum Clinical Chemistry 31(7): 1240-1241